BIOCAPTIVA LIMITED Revenue and Competitors
Estimated Revenue & Valuation
- BIOCAPTIVA LIMITED's estimated annual revenue is currently $775k per year.
- BIOCAPTIVA LIMITED's estimated revenue per employee is $77,500
Employee Data
- BIOCAPTIVA LIMITED has 10 Employees.
- BIOCAPTIVA LIMITED grew their employee count by 11% last year.
BIOCAPTIVA LIMITED's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Clinical Project Manager | Reveal Email/Phone |
BIOCAPTIVA LIMITED Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.7M | 9 | 125% | N/A | N/A |
#2 | $1M | 13 | 0% | N/A | N/A |
#3 | $0.3M | 4 | 0% | N/A | N/A |
#4 | $0.8M | 10 | 11% | N/A | N/A |
#5 | $1.6M | 20 | 67% | N/A | N/A |
What Is BIOCAPTIVA LIMITED?
BIOCAPTIVA is developing the BioCaptor, a revolutionary medical device which has the potential to transform liquid biopsy testing for cancer management, by improving early diagnosis and monitoring of disease and enhancing clinical trial data of cancer patients. The BioCaptor captures up to 100x more cell free DNA (cfDNA) than a venous blood draw, yielding cfDNA in high quality and quantity for testing, addressing the major challenge of liquid biopsy in cancer management. This will potentially allow the testing of a far greater number of cancer types and stages in a much wider range of patients. BIOCAPTIVA was founded in 2021 when it spun out from the University of Edinburgh. BIOCAPTIVA is based in Edinburgh and backed by Archangels and Scottish Enterprise. For more information, please visit www.biocaptiva.com
keywords:N/AN/A
Total Funding
10
Number of Employees
$775k
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 10 | 0% | N/A |
#2 | $0.9M | 10 | N/A | N/A |
#3 | $0.9M | 10 | N/A | N/A |
#4 | $0.9M | 10 | 11% | N/A |
#5 | $0.9M | 10 | -9% | N/A |